Fixed combination dual antiplatelet therapy and the risk of stent thrombosis

Int J Cardiol. 2014 Jun 15;174(2):e79-80. doi: 10.1016/j.ijcard.2014.04.139. Epub 2014 Apr 21.

Authors

Periklis Davlouros¹, Vasileios Gkizas², Spyridon Deftereos³, Georgios Giannopoulos³, Dimitrios Alexopoulos²

Affiliations

¹ Cardiology Department, Patras University Hospital, Patras, Greece. Electronic address: pdav@med.upatras.gr.
² Cardiology Department, Patras University Hospital, Patras, Greece.
³ Athens General Hospital "G. Gennimatas", Athens, Greece; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.

PMID: 24794961
DOI: 10.1016/j.ijcard.2014.04.139

No abstract available

Keywords: Dual antiplatelet therapy; Fixed combination; Optical coherence tomography; Stent thrombosis.

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Aspirin / administration & dosage*
Clopidogrel
Coronary Thrombosis / etiology*
Drug Therapy, Combination
Drug-Eluting Stents*
Female
Humans
Medication Adherence
Platelet Aggregation Inhibitors / administration & dosage*
Risk Factors
Ticlopidine / administration & dosage
Ticlopidine / analogs & derivatives*

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine
Aspirin